#Efficacy

Mac n’ Chise 🧬🧫🦠

sailorrooscout

More promising mRNA vaccine data! This time from Moderna. A new Phase II study shows that half-doses (50 μg) of our vaccine appear to be as effective as full doses

Kenny Mathieson

KennyMathieson

Since the UK plan to delay the 2nd Covid vaccine from 3 weeks to 12 weeks was announced, I've felt VERY uneasy.My concerns are principally related to the Pfizer vaccine.Having

Isaac Bogoch

BogochIsaac

1/ Johnson & Johnson #COVID19 vaccine results are out. As per press release, preventing both moderate & severe illness 28 days after vaccination:-66% Overall-72% USA-66% Latin America-57% in South Africahttps://bit.ly/3pwTWiW

Yoong

yoongkhean

I think pharma NDAs r unethical, collectively LMICs should push back & demand transparency to public.This is better for governance & also so that we don’t fall to the pressures

Bob Wachter

Bob_Wachter

As expected, our @washingtonpost editorial today on the delayed second dose vaccine strategy has generated a vigorous and interesting dialogue. https://tinyurl.com/y7c6v9hz Here are my takeaways (a thread): 1/18 The debate

Adam W Gaffney

awgaffney

You probably heard: "We don't know if COVID-19 vaccination protects against transmission."It's an odd statement! Presumably what is meant is: "It almost certainly protects against transmission, but we don't know

Eric Feigl-Ding

DrEricDing

Where are we in the global vaccine race? Here are 9 top vaccines in Phase 3 trials that are being hotly monitored. Pfizer/BioNTech—available soonModerna—approvals soonAstraZeneca/Oxford—early results, repeating low dose w/

Nick Hudson

NickHudsonCT

A quick summary thread on where we are:1. Public health guidelines, in the WHO's case, refreshed in late 2019, ruled out lockdowns & most of the mandated NPIs being deployed.2.

JayEnAar

GorwayGlobal

I actually have sympathy for @BharatBiotech's scientists and the volunteers who took part in their clinical trials so far. They have been let down by bad science and poor regulatory

Katy Stephenson, MD, MPH

k_stephensonMD

There's been some discussion about whether #COVID19 #vaccines should be rolled out as 1 dose instead of 2 (or lower doses). We call this a "dose-sparing" strategy, and it's been

Paras Chopra

paraschopra

1/n Did you know that one in two people don’t keep up with their new year resolutions just after 1st month? Why does that happen to something WE chose OURSELVES?Psychology

Aaron Ginn

aginnt

1/ The COVID law fatigue argument for increase spread is fundamentally flawed and weak as it assumes efficacy. Though people are sick of the nosy, rude, hysterical voices, there is

Anant Bhan

AnantBhan

THE VACCINE DILEMMAThe government has announced an intent to go ahead with vaccination as of 16th Jan 2021 with both Covishield and Covaxin. There is going to be no choice.

Fionna O'Leary, 🕯🇪🇺

fascinatorfun

Pfizer. Israel refers to 30% efficacy “after” the first dose but does not state at what stage they are measuring efficacy as they ARE administering the second dose three weeks

Daniel Cremin ✂️

DanielCreminUK

Amidst all the fireworks over the EU’s reverse ferret on NI let’s not forget the bigger picture:1. The EU’s *still* seeking to limit vaccine exports to 3rd countries.2. Macron baselessly

Dr. Nelly Yatich

YatichN

LONG THREAD. Received questions in my DM about Pfizer vaccine and will attempt to explain based on available info. Early readout of the Phase III clinical trial of Pfizer’s mRNA

By continuing to use the site, you are consenting to the use of cookies as explained in our Cookie Policy to improve your experience.